Notably, the combination effect of PDCD-1 and LAG-3 in the leukocytes of CRC and the epigenetic modifications are important to understand the complex inhibitory immune mechanisms involved in the risk of CRC. This evidence concerns the gene LAG3 and colorectal carcinoma.